Casdin 资本 对 IPSC 的持仓历史
CENTURY THERAPEUTICS INC · 医疗保健
Casdin 资本 在 Q3 2026 的 13F 申报中披露持有 IPSC(CENTURY THERAPEUTICS INC)1,228,190 股,市值约 US$2.1M,约占其申报组合的 0.09%,在其申报持仓中市值排名第 38 位。 Casdin 资本 最近 22 个申报季度中有 22 个季度披露了 IPSC 持仓,最早可追溯至 Q2 2021。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Casdin 资本 对 IPSC 的持仓演变
Casdin 资本 于 Q2 2021 首次披露 IPSC 持仓:3,206,380 股(约 US$94.1M)。 在 22 次申报中,Casdin 资本 2 次增持、3 次减持、16 次保持不变。 最近一期申报(Q3 2026)显示持股 1,228,190 股、市值约 US$2.1M。 持仓曾出现大幅变动:Q2 2024 增持约 62% (随后一个季度股价下跌 33%)、Q4 2024 增持约 62% (随后一个季度股价下跌 53%)、Q2 2025 减持约 62% (随后一个季度股价下跌 11%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2021 | 3.21M | $94.08M | 新进 |
| Q3 2021 | 3.21M | $80.67M | 持有 |
| Q4 2021 | 3.21M | $50.85M | 持有 |
| Q1 2022 | 3.21M | $40.37M | 持有 |
| Q2 2022 | 3.21M | $26.93M | 持有 |
| Q3 2022 | 3.21M | $31.71M | 持有 |
| Q4 2022 | 3.21M | $16.45M | 持有 |
| Q1 2023 | 3.21M | $11.13M | 持有 |
| Q2 2023 | 3.21M | $10.13M | 持有 |
| Q3 2023 | 3.21M | $6.41M | 持有 |
| Q4 2023 | 3.21M | $10.65M | 持有 |
| Q1 2024 | 3.21M | $13.40M | 持有 |
| Q2 2024 | 5.19M | $13.24M | 增持 |
| Q3 2024 | 3.21M | $5.49M | 减持 |
| Q4 2024 | 5.19M | $5.24M | 增持 |
| Q1 2025 | 3.21M | $1.53M | 减持 |
| Q2 2025 | 1.23M | $686.19K | 减持 |
| Q3 2025 | 1.23M | $611.64K | 持有 |
| Q4 2025 | 1.23M | $1.22M | 持有 |
| Q1 2026 | 1.23M | $2.78M | 持有 |
| Q2 2026 | 1.23M | $3.01M | 持有 |
| Q3 2026 | 1.23M | $2.10M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 IPSC 与 13F 数据
IPSC(CENTURY THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 41 只申报持有 IPSC,申报仓位最大的包括:TCG Crossover Management, LLC (US$30.4M), RA CAPITAL MANAGEMENT, L.P. (US$30.4M), Versant Venture Management, LLC (US$20.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 IPSC 的基金
- TCG Crossover Management, LLC 17.75M 股 · $30.36M · Q3 2026
- RA CAPITAL MANAGEMENT, L.P. 17.75M 股 · $30.36M · Q3 2026
- Versant Venture Management, LLC 12.17M 股 · $20.80M · Q3 2026
- Commodore Capital LP 8.70M 股 · $14.87M · Q3 2026
- Venrock Adviser, LLC 8.70M 股 · $14.87M · Q3 2026
- Trails Edge Capital Partners, LP 4.13M 股 · $7.07M · Q3 2026
- Spruce Street Capital LP 4.06M 股 · $6.94M · Q3 2026
- Seven Fleet Capital Management LP 4.42M 股 · $6.08M · Q3 2026
- STEMPOINT CAPITAL LP 2.56M 股 · $4.38M · Q3 2026
- DAFNA Capital Management LLC 2.39M 股 · $4.08M · Q3 2026
更多关于 Casdin 资本
常见问题
How long has Casdin 资本 held IPSC?
Casdin 资本 has disclosed IPSC holdings in 22 of the last 22 reported quarters, going back to Q2 2021.
What is Casdin 资本's current position in IPSC?
As of Q3 2026, Casdin 资本 holds 1.23M shares of IPSC (CENTURY THERAPEUTICS INC), valued at $2.10M, representing 0.09% of its reported portfolio and ranking #38.
Has Casdin 资本 been buying or selling IPSC?
In the latest 13F filing (Q3 2026), Casdin 资本 held unchanged its position in IPSC.
Which other funds hold IPSC?
Other major institutional holders of IPSC include TCG Crossover Management, LLC, RA CAPITAL MANAGEMENT, L.P., Versant Venture Management, LLC, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.